Navigation Links
Uric Acid Colorimetric Assay Kit, QuantiChrom from BioAssay Systems

ProductsUric Acid Colorimetric Assay Kit, QuantiChrom from BioAssay Systems
Company BioAssay Systems
Item Uric Acid Colorimetric Assay Kit, QuantiChrom
Price $259.00
Description One-step, microplate or cuvet, colorimetric, linear detection range 0.2 mg/dL to 20 mg/dL. Procedure: 20 min.
Info BioAssay SystemsBioAssay Systems
3423 Investment Blvd.
Suite 11
Hayward, CA 94545

Call BioAssay Systems to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-510-962-4900
Customer Service: (510) 782-9988
Fax Number: (510) 782-1588
Web Site: http://www.bioassaysys.com/index.html
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
2. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
3. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
4. Phosphate Colorimetric Assay Kit, EnzoLyte from AnaSpec
5. Cell Transformation Colorimetric Assay Kit from CHEMICON
6. NADPH-cytochrome c reductase Colorimetric Assay Kit from Sigma-Aldrich
7. Cell Invasion Colorimetric Assay Kit from CHEMICON
8. Angiotensin Converting Enzyme Colorimetric Assay Kit from Alpco Diagnostics
9. Plasminogen Activator Inhibitor (PAI-1) Colorimetric Assay Kit from AMERICAN DIAGNOSTICA
10. Protein Detector Microarray Dot Blot Kit, AP Colorimetric from KPL
11. XpressPack™ Colorimetric Amplification Detection System, required for colorimetric XpressPack™ from CHEMICON
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 1Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 3Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 1Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 2Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5
Breaking Biology Technology:BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5